Page 11234..1020..»

Category Archives: Clinical Cardiology

Polygenic Risk Score Not Found to Enhance CHD Risk Prediction of Clinical Risk Score – The Cardiology Advisor

Posted: March 14, 2020 at 3:47 pm

The polygenic risk score was not found to be superior to the clinical risk score in predicting the occurrence or risk stratification of incident coronary heart disease (CHD), according to study results published in JAMA. Continue reading

Posted in Clinical Cardiology | Comments Off on Polygenic Risk Score Not Found to Enhance CHD Risk Prediction of Clinical Risk Score – The Cardiology Advisor

Reviewing Evidence on the Screening, Diagnosis, and Care of Familial Hypercholesterolemia – The Cardiology Advisor

Posted: at 3:47 pm

Familial hypercholesterolemia (FH) is one of the most clinically relevant monogenic disorders contributing to the development of atherosclerotic cardiovascular disease (ASCVD). The prevalence of FH was estimated to be 1 in 200 to 1 in 250 individuals in studies in which genetic testing was conducted on large community population samples.1 However, the disease often remains undetected and thus untreated, with only 10% of individuals with FH receiving adequate diagnosis and treatment.2 Noting the recent accumulation of studies on FH, the authors of a Nature Reviews Cardiology article sought to summarize the key elements of a model of care for the condition that can be adapted as new evidence emerges.1 Selected points are highlighted below. Screening and detection. Continue reading

Posted in Clinical Cardiology | Comments Off on Reviewing Evidence on the Screening, Diagnosis, and Care of Familial Hypercholesterolemia – The Cardiology Advisor

COVID-19 and the Heart: Insights From the Front Lines – TCTMD

Posted: at 3:47 pm

As the number of COVID-19 casesand panicspreads throughout the globe, a picture is emerging as to what the direct cardiovascular effects of this particular coronavirus (SARS-CoV-2) might be and what the indirect impact will be on cardiologists and the patients in their care. Continue reading

Posted in Clinical Cardiology | Comments Off on COVID-19 and the Heart: Insights From the Front Lines – TCTMD

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease – TCTMD

Posted: at 3:47 pm

More time spent in ideal cardiovascular health, starting as early as childhood, is associated not only with less subclinical atherosclerosis, but also with significant improvements in cardiometabolic health and a lower risk of all-cause mortality, according to the results of two new studies published this week in JAMA Cardiology. In the first study, which was led by Vanessa Xanthakis, PhD (Boston University School of Medicine, MA), and Laura Corlin, PhD (Tufts University School of Medicine, Boston), longer durations of ideal or intermediate CV health in midlife were associated with lower risks of developing hypertension, diabetes, chronic kidney disease, CVD, and all-cause mortality when compared with men and women in poor CV health. You dont have to be perfect, but the closer you are to a better overall lifestyle, the better off you are, Xanthakis told TCTMD. Continue reading

Posted in Clinical Cardiology | Comments Off on Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease – TCTMD

University Hospitals and Cleveland Clinic Partner to Provide Drive-Through COVID-19 Testing – Health Essentials from Cleveland Clinic

Posted: at 3:47 pm

Cleveland Clinic and University Hospitals (UH) have partnered to provide drive-through COVID-19 testing for patients with a doctors order from UH or Cleveland Clinic. Continue reading

Posted in Clinical Cardiology | Comments Off on University Hospitals and Cleveland Clinic Partner to Provide Drive-Through COVID-19 Testing – Health Essentials from Cleveland Clinic

Systemic Sclerosis Myocarditis Associated With Higher Degrees of Myocardial Fibrosis – The Cardiology Advisor

Posted: March 4, 2020 at 1:44 am

Systemic sclerosis (SSc) myocarditis was found to occur more frequently in individuals with heart failure and a higher dyspnea class; SSc-myocarditis was also found to be associated with higher degrees of myocardial fibrosis, according to study results published in Rheumatology. According to the researchers, a comprehensive description and distinctive representation of SSc myocarditis is currently lacking, but it is needed to accurately identify the disease in its early stages to initiate therapy Continue reading

Posted in Clinical Cardiology | Comments Off on Systemic Sclerosis Myocarditis Associated With Higher Degrees of Myocardial Fibrosis – The Cardiology Advisor

Study Assesses the Prevalence of Clinically Relevant Aortic Dilatation in Aging Masters-Level Athletes – DocWire News

Posted: at 1:44 am

A new study highlighted the relationship between ascending aortic dilatation and long-term endurance exercise in aging masters-level athletes. Continue reading

Posted in Clinical Cardiology | Comments Off on Study Assesses the Prevalence of Clinically Relevant Aortic Dilatation in Aging Masters-Level Athletes – DocWire News

Europe deserves more and better research & innovation in cardiovascular disease – Open Access Government

Posted: at 1:44 am

Europe has a history of strong biomedical heart research and impactful clinical studies, which have resulted in improving cardiovascular health. Despite a period of decline in cardiovascular-related mortality thanks to the introduction of new treatments and prevention measures, cardiovascular disease (CVD) is levelling off and remains the leading cause of death worldwide and a major burden to society. Worryingly, there is a wrong perception that prevention is sufficient to tackle the burden of CVD Continue reading

Posted in Clinical Cardiology | Comments Off on Europe deserves more and better research & innovation in cardiovascular disease – Open Access Government

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online – BioSpace

Posted: at 1:44 am

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invasive devices for the treatment of refractory angina, announced today the Neovasc Reducer (the "Reducer") was featured in the peer reviewed publicationEuroIntervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and highlighted inPCR Online. Continue reading

Posted in Clinical Cardiology | Comments Off on Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online – BioSpace

Advanced imaging tools transforming Heart Care – ETHealthworld.com

Posted: at 1:44 am

New Delhi: Turning a corner in interventional cardiology, advanced tools have opened new frontiers in heart care. Continue reading

Posted in Clinical Cardiology | Comments Off on Advanced imaging tools transforming Heart Care – ETHealthworld.com

Page 11234..1020..»